4.7 Review

Combining evidence from Mendelian randomization and colocalization: Review and comparison of approaches

期刊

AMERICAN JOURNAL OF HUMAN GENETICS
卷 109, 期 5, 页码 767-782

出版社

CELL PRESS
DOI: 10.1016/j.ajhg.2022.04.001

关键词

-

资金

  1. Sir Henry Dale Fellowship - Wellcome Trust
  2. Royal Society [204623/Z/16/Z]
  3. Wellcome Trust [WT220788]
  4. United Kingdom Research and Innovation Medical Research Council [MC_UU_00002/4, MC_UU_00002/7]
  5. GSK
  6. MSD
  7. National Institute for Health Research Cambridge Biomedical Research Centre [BRC-1215-20014]

向作者/读者索取更多资源

Mendelian randomization and colocalization are statistical approaches used to understand relationships between traits and diseases. They differ in their objectives and interpretation. Mendelian randomization assesses causality between exposure and outcome, while colocalization assesses whether two traits are affected by the same or distinct causal variants.
Mendelian randomization and colocalization are two statistical approaches that can be applied to summarized data from genome-wide association studies (GWASs) to understand relationships between traits and diseases. However, despite similarities in scope, they are different in their objectives, implementation, and interpretation, in part because they were developed to serve different scientific communities. Mendelian randomization assesses whether genetic predictors of an exposure are associated with the outcome and interprets an association as evidence that the exposure has a causal effect on the outcome, whereas colocalization assesses whether two traits are affected by the same or distinct causal variants. When considering genetic variants in a single genetic region, both approaches can be performed. While a positive colocalization finding typically implies a non-zero Mendelian randomization estimate, the reverse is not generally true: there are several scenarios which would lead to a non-zero Mendelian randomization estimate but lack evidence for colocalization. These include the existence of distinct but correlated causal variants for the exposure and outcome, which would violate the Mendelian randomization assumptions, and a lack of strong associations with the outcome. As colocalization was developed in the GWAS tradition, typically evidence for colocalization is concluded only when there is strong evidence for associations with both traits. In contrast, a non-zero estimate from Mendelian randomization can be obtained despite only nominally significant genetic associations with the outcome at the locus. In this review, we discuss how the two approaches can provide complementary information on potential therapeutic targets.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据